[After tumor therapy what possibilities exist for preservation of female fertility?].
Kelm-Kahl
Inge
I
D000293:Adolescent; D000328:Adult; D000568:Amenorrhea / Q000139:chemically induced*; D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000628:therapy; D002648:Child; D015925:Cryopreservation; D004622:Embryo, Mammalian; D016889:Endometrial Neoplasms / Q000628:therapy; D005260:Female; D005298:Fertility / Q000187:drug effects; D005307:Fertilization in Vitro; D006801:Humans; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D009867:Oogonia / Q000502:physiology; D006080:Ovarian Follicle / Q000528:radiation effects; D010053:Ovary / Q000528:radiation effects / Q000637:transplantation*; D010063:Ovum / Q000502:physiology; D011247:Pregnancy; D011878:Radiotherapy / Q000009:adverse effects; D012307:Risk Factors; D002583:Uterine Cervical Neoplasms / Q000628:therapy
D000970:Antineoplastic Agents